Category Archives: XBI

Biotech (short) Set-Up

October 9, 2025 By in $SPSIBI, IBB, LABD, LABD-25-13, Positions, SPBIO, Up-Thrust, XBI 3 Comments

Breakout Into Resistance

Both biotech funds, IBB, and XBI, are now in an up-thrust (potential reversal) condition.

In each case, the ETFs have pushed through a long-established trading range, straight into resistance.

The last update focused on less liquid IBB, because it was not known if heavily traded XBI, would push through its trading range (being the weaker of the two).

Since that initial update, both indices are now above their trading range.

Of course, what happens next is the question.

Biotech XBI, Weekly

The blue line is long established resistance.

The black dashed line is the top of the trading range and the up-thrust condition.

At this point anything can happen.

XBI, could reverse immediately or grind its way along, dissipate momentum, or even move higher.

We’re at the point where the risk of being wrong on a short position is least (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

‘Bubble’ & The ‘Beast’

September 26, 2025 By in $SPSIBI, Artificial Intelligence, Biotech, BIS, IBB, Positions, Semiconductors, SOXS, SOXX, SOXX-25-14, SPBIO, Up-Thrust, Wyckoff, XBI 3 Comments

Downside For Both?

The ‘bubble’ is obvious, Artificial Intelligence.

The ‘beast’, not so much, but revealed below.

The last update, presented a case for the SOXX top, a proxy for A.I.

Note: If the SOXX, has made its final high, it’s still very early in the reversal:

Wyckoff said a century ago, ‘It’s as if the weight of a feather can move the market in either direction’.

That’s where we are now.

For biotech (IBB, XBI), different forces are at work.

Biotech IBB, Weekly

The 38.2%, retrace from 9/19 high, to 9/25 low, is in the vicinity of 140.90 (magenta dashed line).

Fridays are typically biased to the upside.

There’s a possibility IBB, may test (upward) throughout the session, heading to (at or near) 38%, by the end of the day (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Auto Lender’s Implosion

September 21, 2025 By in $SPSIBI, 2007 - 2008, ALLY, Biotech, CVNA, SPBIO, XBI

One of Many?

The last melt-down in 2008 – 2009, was precipitated by subprime mortgage.

This time, will it be auto loans?

Is this just one of many implosions to come?

Digging-in on auto finance, we have chief cook and bottle washer, Ally Financial. Old timers know this outfit as formerly GMAC.

Let’s not forget, Carvana (CVNA) and Ally are (potentially) joined at the hip, link here.

Moving on to the chart.

Ally Financial, ALLY, Weekly

This price action is eerily similar to biotech.

Note how long ALLY bounced around below support (in spring position) before finally moving to the upside.

Nearly a month ‘hugging the lows’, could be an underlying indication of weakness (not advice, not a recommendation).

The next earnings release is scheduled for October 17th.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Early Session: Biotech

September 19, 2025 By in $SPSIBI, Biotech, GLD, Gold & Silver, Gold Miners, LABD, LABD-25-12, Positions, SPBIO, Spring-to-Up-Thrust, Up-Thrust, XBI

Repeating Pattern

The graphic at left, is a segment of biotech tracking ETF, XBI.

Note how it exhibits a repeating pattern of spring-to-up-thrust (S & U).

Today is also Fibonacci ‘Day 5’, from the ‘S’ labeled low.

As seen with gold GLD, slightly higher, not correcting immediately, anything can happen.

However, with XBI, we’re in a multi-year downtrend that may be finishing its countertrend move, ready to up-thrust and reverse lower (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Margin Debt … $1-Trillion

September 18, 2025 By in $SPSIBI, Biotech, DIA, IBB, IWM, IYR, LABD, LABD-25-11, Positions, QQQ, S&P, S&P 500, SPBIO, SPY, Up-Thrust, Wyckoff, XBI, XLF, ZeroHedge

When it Implodes

Is the bell ringing?

Is this it?

In the pre-market, SPY, DIA, XLF, QQQs, all-time highs.

Meanwhile, beneath the surface, it’s getting a bit ‘uncomfortable’.

One Trillion in margin debt as reported here and here.

The Ones To Watch

While all eyes are focused on the leaders (above), at least three markets are not participating:

Real Estate, IYR, Russell IWM, biotech, IBB, and XBI.

From a Wyckoff perspective, for short candidates, these are the ones to watch (not advice, not a recommendation).

Biotech, XBI

As stated in the prior update, XBI may have formed a triple top within and ‘up-thrust’, link here.

The obvious areas to watch for today’s session, are yesterday’s high and low.

A new high puts the up-thrust into question; new low, adds (a small) confirmation to reversal.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Rate Cut … Now, What?

September 17, 2025 By in Biotech, Federal Reserve, Interest Rates, LABD, LABD-25-11, Michael Bordenaro, Positions, ShadowStats, SPBIO, XBI

Think, ‘Outside The Herd’

Michael Bordenaro, spells out the current jobs situation from a ‘boots on the ground’ perspective, link here.

From the video and comments, the agreement seems to be, unemployment is much higher than 5%.

Of course, if one is interested, more accurate job numbers (and inflation numbers) are at this link.

Separately, it appears that biotech XBI, has made a triple-top (not advice, not a recommendation).

More on that, later.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Breakout or Breakdown … Biotech

September 16, 2025 By in $SPSIBI, Federal Reserve, Interest Rates, LABD, LABD-25-11, MyStrategicForecast, Positions, QQQ, SPBIO, SPY, Up-Thrust, XBI 2 Comments

‘Winds of Change‘

The last update said, XBI presented the ‘best (index) short opportunity’ (not advice, not a recommendation).

Is that still true?

With the SPY and Qs, still grinding higher, XBI is absent, having topped four days ago.

It’s not necessarily the top per se, but the XBI location in the overall market.

While the major indices are just now reaching all-time highs, biotech XBI, posted all-time highs years ago.

Four and a half years, to be more precise.

Biotech XBI, Daily

Today’s action can be considered as a ‘test’ of the attempted (possibly failed) breakout.

There’s ‘evidence of a struggle’ and XBI is not (at this time) moving higher.

Adding to that, we have what’s been referred to as ‘Kabuki Theater‘ coming up at 2:00 p.m., EST, tomorrow).

Let’s see what happens next.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech … The Big One?

September 10, 2025 By in $SPSIBI, Biotech, GDX, GDXJ, Gold & Silver, Gold Miners, Greg Hunter, HOOD, IBB, Karen Kingston, LABD, LABD-25-10, Nasdaq, ORCL, Positions, QQQ, S&P, S&P 500, SPBIO, Speck-Effect, SPY, The Speck, XBI 3 Comments

Next Leg Lower

Unfortunately, the (mad scientist) graphic at left, is not too far removed from what’s really going on in biotech.

While the S&P, Nasdaq Qs, Gold Miners, Semiconductors, Financials, The HOOD, ORCL, and others, continue to make all-time highs, conspicuously absent is biotech, XBI and IBB.

Now, it appears that quietly, in the background, XBI is reversing to the downside.

Biotech XBI, Daily Close

The up-thrust is there, but is a weak penetration of resistance.

Even so, on the ‘test’, volume contracted by -49.24%, when compared to volume on the upside penetration.

Until proven otherwise, this set-up appears to (currently) be the best short opportunity.

With that said, all other short positions have been closed to focus on biotech.

Leveraged inverse fund LABD is being used at this juncture: Trade LABD-25-10, with stop at the session low (not advice, not a reocmmendiaton).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

The Famous ‘Reversal’

August 29, 2025 By in 1929, Biotech, Great Depression, Great Depression 2.0, Positions, SPBIO, XBI, XBI-25-03

Back in The Day

So, here we are nearly on the eve of the most significant reversal, ever:

September 3rd, 1929

That is, maybe, until now.

Today’s downside action may turn out to be just a blip; much ado about nothing.

Or it could be the harbinger of a top. Maybe the top (not advice, not a recommendation).

Biotech sector XBI, appears to be losing steam while at the same time, being in up-thrust (potential false breakout) condition.

As of this post (12:10 p.m., EST), XBI is down -0.63%, and has posted a new daily low. Short position XBI-25-03, remains active (not advice, not a recommendation).

We’ll discuss this index and others over the long weekend.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech … It’s Not a Bull Market

August 27, 2025 By in $SPSIBI, Biotech, Financial Sector, Positions, SPBIO, Up-Thrust, XBI, XBI-25-03, XLF, XLF-25-06

The Big Picture

Each market session provides another data point, bull, bear, or congestion.

Yesterday’s position in XLF, was stopped out the same day with a minuscule loss.

That trade was an excellent example of operating at the market’s edge and maintaining discipline.

Another data point.

However, one market not making new highs, or threatening the current short position (yet), was biotech, XBI; short trade XBI-25-03.

So, let’s take a look at what’s really going on.

Biotech Sector SPBIO, Daily Close

We’re far away from all-time highs.

The Fibonacci retracements are shown.

At this point, we’re oscillating around the 23.6%, and in up-thrust condition.

The second chart zooms-in on the set-up.

Set-ups don’t guarantee anything.

They just mean the market has reached a point where risk could be at a minimum.

Bull or Bear

With the SPBIO (XBI as the proxy), we either have a breakout above resistance or an up-thrust as previously mentioned.

Until the market proves otherwise by making new daily highs, the condition continues to be traded as a potential (significant) downside reversal (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279